PA
KPRX icon

Perceptive Advisors’s Kiora Pharmaceuticals KPRX Stock Holding History

Perceptive Advisors’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Buy
+438,471
New +$1.1M 0.02% 103

Other funds holding KPRX

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Perceptive Advisors's KPRX Position: Q2 2026 in Review

Perceptive Advisors opened a new position in Kiora Pharmaceuticals (KPRX) in Q2 2026: 438,471 shares worth $1.15M. The stake represents 0.02% of the portfolio and ranks #103 among its holdings.

22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Perceptive Advisors held 438,471 shares of Kiora Pharmaceuticals worth $1.15M as of Q2 2026.
  • Kiora Pharmaceuticals was a new Perceptive Advisors position in Q2 2026.
  • Kiora Pharmaceuticals made up 0.02% of Perceptive Advisors's portfolio in Q2 2026, its #103 holding.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.